By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech To Present New Data At The 2016 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting 2/10/2016 10:11:56 AM
DBV Tech Proudly Welcomes Edward Jordan As Senior Vice President Commercial Operations North America 1/26/2016 9:16:07 AM
DBV Tech Announces 2016 Financial Calendar 1/8/2016 10:28:53 AM
DBV Tech Release: First Experimental Results For The Treatment Of Colitis With Viaskin Will Be Presented At The Crohn's & Colitis Foundation Of America's 2015 Advances In IBD Conference (AIBD) 12/10/2015 2:20:03 PM
DBV Tech Announces Initiation Of Phase III Study Of Viaskin Peanut For The Treatment Of Peanut Allergic Children 12/8/2015 4:16:36 PM
DBV Tech To Present Preclinical Data On Its Viaskin Technology For RSV Vaccination At The 2015 RSV Vaccines For The World Meeting 11/18/2015 10:08:12 AM
DBV Tech Announces Enrollment Of First Patient In Phase IIA Study In Pediatric Eosinophilic Esophagitis 11/13/2015 9:51:37 AM
DBV Tech Reports Interim Financial Results For The Third Quarter Of 2015 11/3/2015 9:16:07 AM
DBV Tech Announces The Appointment Of Michael J. Goller To Its Board Of Directors 10/23/2015 10:12:29 AM
DBV Tech Announces First Patient Enrolled In Phase II Study Of Viaskin Milk 10/14/2015 10:08:26 AM